Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen.

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2020)

ClinicalTrials.gov identifier, NCT02750410.

Keyphrases